Sir Alexander Fred Markham, born 1950, is Professor of Medicine at the University of Leeds, Director of the Molecular Medicine Institute at St James's University Hospital, and a former Chief Executive of Cancer Research UK.
Markham graduated from the University of Birmingham with a BSc in Chemistry in 1971 and a PhD, also in Chemistry, in 1974. [1] He qualified in Medicine in 1985 at the Universities of London and Oxford. [2]
Markham has been one of the pioneers of molecular genetics research in the UK since the late 1980s. His work has included the development of DNA Fingerprinting, work which received the Queen's Award for Technological Achievement in 1990. He has been a Professor of Medicine at the University of Leeds since 1993.
Markham serves on a number of Advisory Panels for the Medical Research Council and the Department of Health. He is Chairman of the Office for the Strategic Coordination of Health Research (OSCHR) Translational Medicine Board.
He is a fellow of the Academy of Medical Sciences and a former Chairman of the National Cancer Research Institute.
Markham also advises the German government on its cancer research strategy.
Markham's late wife Dr Lisa Brown, Lady Markham, was an expert biochemist and a member of the British Toxicology Society. She worked as a Chartered Patent Attorney. [3] The couple have two children; Grace and James. Markham is a fan of Manchester City.
Markham received a knighthood in the 2008 New Year Honours for services to medicine. [4]
He has been awarded honorary degrees from:
Professor Markham sits on the boards of many charities, including:
The University of Texas Southwestern Medical Center is a public academic health science center in Dallas, Texas. With approximately 23,000 employees, more than 3,000 full-time faculty, and nearly 4 million outpatient visits per year, UT Southwestern is the largest medical school in the University of Texas System and the State of Texas.
The Medical Research Council (MRC) is responsible for co-coordinating and funding medical research in the United Kingdom. It is part of United Kingdom Research and Innovation (UKRI), which came into operation 1 April 2018, and brings together the UK's seven research councils, Innovate UK and Research England. UK Research and Innovation is answerable to, although politically independent from, the Department for Business, Energy and Industrial Strategy.
The Temerty Faculty of Medicine is the medical school of the University of Toronto. Founded in 1843, the faculty is based in Downtown Toronto and is one of Canada's oldest institutions of medical studies, being known for the discovery of insulin, stem cells and the site of the first single and double lung transplants in the world.
Sir James Fraser Stoddart is a British-American chemist who is Board of Trustees Professor of Chemistry and head of the Stoddart Mechanostereochemistry Group in the Department of Chemistry at Northwestern University in the United States. He works in the area of supramolecular chemistry and nanotechnology. Stoddart has developed highly efficient syntheses of mechanically-interlocked molecular architectures such as molecular Borromean rings, catenanes and rotaxanes utilising molecular recognition and molecular self-assembly processes. He has demonstrated that these topologies can be employed as molecular switches. His group has even applied these structures in the fabrication of nanoelectronic devices and nanoelectromechanical systems (NEMS). His efforts have been recognized by numerous awards, including the 2007 King Faisal International Prize in Science. He shared the Nobel Prize in Chemistry together with Ben Feringa and Jean-Pierre Sauvage in 2016 for the design and synthesis of molecular machines.
The Academy of Medical Sciences is an organisation established in the UK in 1998. It is one of the four UK National Academies, the others being the British Academy, the Royal Academy of Engineering and the Royal Society.
Sir Michael James Paul Arthur FMedSci is a British academic who was the tenth provost and president of University College London between 2013 and January 2021. Arthur had previously been chairman of the Russell Group of UK universities and the vice-chancellor of the University of Leeds between September 2004 and 2013.
Sir Hans Leo Kornberg, FRS was a British-American biochemist. He was Sir William Dunn Professor of Biochemistry in the University of Cambridge from 1975 to 1995, and Master of Christ's College, Cambridge from 1982 to 1995.
Abass Alavi is an Iranian-American physician-scientist specializing in the field of molecular imaging, most notably in the imaging modality of positron emission tomography (PET). In August 1976, he was part of the team that performed the first human PET studies of the brain and whole body using the radiotracer [18F]Fluorodeoxyglucose (FDG). Alavi holds the position of Professor of Radiology and Neurology, as well as Director of Research Education in the Department of Radiology at the University of Pennsylvania. Over a career spanning five decades, he has amassed over 2,300 publications and 60,000 citations, earning an h-index of 125 and placing his publication record in the top percentile of scientists.
Sir John Irving Bell is a Canadian-British immunologist and geneticist. From 2006 to 2011, he was President of the United Kingdom's Academy of Medical Sciences, and since 2002 he has held the Regius Chair of Medicine at the University of Oxford. He was since 2006 Chairman of the Office for Strategic Coordination of Health Research (OSCHR) but in 2020 became a normal member. Bell was selected to the Vaccine Taskforce sometime before 1 July 2020. Bell is also on the board of directors of the SOE quango Genomics England.
The School of Biological Sciences is a research-led academic community at the University of East Anglia. It works with partners in industry on a range of activities, including translating research discoveries into products, making knowledge and research expertise available through consultancies, contract research and provision of analytical services, as well as partnering industry in training both undergraduate and postgraduate students.
Sir Gordon William Duff, is a British medical scientist and academic. He was Principal of St Hilda's College, Oxford, from 2014 to 2021. He was Lord Florey Professor of Molecular Medicine at the University of Sheffield from 1991 to 2014.
Shirley Victoria Penrose Hodgson, FRCP, FRSB is a British geneticist.
Roger Sidney Goody is an English biochemist who served as director at the Max Planck Institute for Molecular Physiology in Dortmund from 1993 until 2013. Since 2013 he is Emeritus Director of the institute.
Pamela J. Russell was an Australian academic researcher of immunology, bladder and prostate research. Russell was awarded Membership of the Order of Australia (AM) for her research on prostate and bladder cancer in 2003.
Professor Sir Norman Stanley Williams is a British surgeon and former President of the Royal College of Surgeons of England (2011–14).
Moira Katherine Brigid Whyte FERS is a Scottish physician and medical researcher who is the Sir John Crofton Professor of Respiratory Medicine at the University of Edinburgh. She is the Director the Medical Research Council Centre for Inflammation Research and is Vice-Principal and Head of the College of Medicine and Veterinary Medicine at the University of Edinburgh. Whyte is also a trustee of Cancer Research UK.
Kelly Chibale PhD, FRSSAf, FRSC is professor of organic chemistry at the University of Cape Town, and the founder and director of H3D research center. In 2018 he was recognized as one of Fortune magazine's top 50 World's Greatest Leaders. His research focuses on target-directed inhibitors.
Lisa O. Roberts is vice chancellor and President of the University of Exeter. She took over from professor Steve Smith on his retirement on 1 September 2020.
Sir Andrew John Pollard is the Ashall Professor of Infection & Immunity at the University of Oxford and a Fellow of St Cross College, Oxford. He is an Honorary Consultant Paediatrician at John Radcliffe Hospital and the Director of the Oxford Vaccine Group. He is the Chief Investigator on the University of Oxford COVID-19 Vaccine trials and has led research on vaccines for many life-threatening infectious diseases including typhoid fever, Neisseria meningitidis, Haemophilus influenzae type b, streptococcus pneumoniae, pertussis, influenza, rabies, and Ebola.